Veeva Systems Inc. provides cloud-based software for the life sciences industry in North America, Europe, the Asia Pacific, the Middle East, Africa, and Latin America. The company offers Veeva Commercial Cloud, a suite of software, data, and analytics solutions, which include Veeva customer relationship management (CRM) and Veeva Medical CRM, Veeva CLM, Veeva CRM Approved Email, Veeva CRM Engage, Veeva Align, Veeva CRM Events Management, Veeva Nitro, Veeva Andi, Veeva OpenData, Veeva Link, Veeva Network Customer Master, Veeva Crossix, Veeva Data Cloud, and MyVeeva for Doctors; and Veeva Vault, a cloud-based enterprise content and data management applications for managing commercial functions, including sales and marketing, and medical content and communications, as well as research and development functions, such as clinical, regulatory, quality, and safety. It also provides professional and support services in the areas of implementation and deployment planning and project management; requirements analysis, solution design, and configuration; systems environment management and deployment services; services focused on advancing or transforming business and operating processes related to Veeva solutions; technical consulting services related to data migration and systems integrations; training on its solutions; and ongoing managed services that include outsourced systems administration. The company was formerly known as Verticals onDemand, Inc. and changed its name to Veeva Systems Inc. in April 2009. Veeva Systems Inc. was incorporated in 2007 and is headquartered in Pleasanton, California.
IPO Year: 2013
Exchange: NYSE
Website: veeva.com
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 9/8/2025 | $330.00 | Neutral → Overweight | Analyst |
| 5/29/2025 | $270.00 → $300.00 | Buy | Needham |
| 1/23/2025 | $261.00 → $200.00 | Buy → Sell | Goldman |
| 12/20/2024 | $280.00 | Overweight | Stephens |
| 12/4/2024 | $275.00 | Outperform | Mizuho |
| 11/19/2024 | $235.00 | Sector Perform | Scotiabank |
| 10/8/2024 | $286.00 | Outperform | Exane BNP Paribas |
| 8/27/2024 | $256.00 → $273.00 | Buy | Citigroup |
| 7/9/2024 | $240.00 | Buy | BTIG Research |
| 10/25/2023 | $211.00 → $229.00 | Equal Weight → Overweight | Wells Fargo |
Fastest customizable press release news feed in the world
Report shows completing manual data reconciliation, cleaning, and review takes each data manager more than 12 hours per week, per study BALTIMORE, Sept. 29, 2025 /PRNewswire/ -- SCDM 2025 — Two-thirds of data managers and clinical research associates (CRAs) report that inefficiencies in manual data reconciliation, cleaning, and review will put clinical data quality at future risk. The Veeva Clinical Data Industry Research shows the main drivers adding time and effort in executing clinical trials are too many manual steps or data re-entry (68%), inefficient workflows (58%), and using multiple disconnected systems (59%). The findings highlight a need to automate the most inefficient data manag
PLEASANTON, Calif., Sept. 25, 2025 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) will host its investor day virtually on Thursday, October 16, 2025. The event will begin at 1:30 p.m. PT and will conclude at approximately 3:30 p.m. PT. Veeva will broadcast the presentations live on the company's investor relations website, ir.veeva.com, where a link to the archived webcast will also be available after the event. Event: Veeva Systems 2025 Investor Day Date: Thursday, October 16, 2025 Time: 1:30 p.m. PT (4:30 p.m. ET) Online event registration can be found on the company's investor relations website or directly at this link. Webcast: ir.veeva.com About Veeva SystemsVeeva delivers the indust
For next-generation CRM with deep, industry-specific AI agents PLEASANTON, Calif., Sept. 22, 2025 /PRNewswire/ -- Veeva Systems (NYSE:VEEV) today announced that Bristol Myers Squibb (BMS) has committed to Veeva Vault CRM. "Technology is fundamentally reshaping the way we engage with our customers and the patients they serve," said Greg Meyers, executive vice president, chief digital and technology officer at Bristol Myers Squibb. "We are excited to take the next step in our long-standing relationship with Veeva by using Vault CRM to help transform how healthcare practitioners
Next generation CRM with deep capabilities and agentic AI PLEASANTON, Calif., Sept. 10, 2025 /PRNewswire/ -- Veeva Systems (NYSE:VEEV) today announced that Gilead Sciences has committed to Veeva Vault CRM. "Gilead is a leader in life changing medicines and has been a pioneer of major scientific advancements in virology, inflammation, and oncology," said Veeva CEO Peter Gassner. "We are honored to be a strategic partner to Gilead and extend that partnership to Vault CRM." "We are excited to expand our long-standing partnership with Veeva by moving to Vault CRM," said Anna Åsber
PLEASANTON, Calif., Sept. 2, 2025 /PRNewswire/ -- Veeva Systems (NYSE:VEEV) today announced participation in the following investor conferences: Citi's 2025 Global TMT Conference, New York, NY. Brian Van Wagener, CFO, and Paul Shawah, EVP Strategy, will present on Thursday, September 4, 2025, at 2:10 p.m. Eastern Time.The above presentations will be webcast. Links to the live and archived webcast will be available on Veeva's investor relations website at https://ir.veeva.com. About Veeva SystemsVeeva is the global leader in cloud software for the life sciences industry. Committed to innovation, product excellence, and customer success, Veeva serves more than 1,500 customers, ranging from th
Advanced regulatory capabilities and new industry partnerships accelerate collaboration with global health authorities PLEASANTON, Calif., Sept. 2, 2025 /PRNewswire/ -- Veeva Systems (NYSE:VEEV) today announced more than 450 companies, including 19 of the top 20 biopharmas, have adopted Veeva RIM for regulatory information management (RIM) on a unified platform. Continued innovation to advance connectivity now includes partnerships with Accumulus Technologies and DNAnexus, enabling integration with multi-health authority platforms to drive efficiency and compliance. "Regulator
PLEASANTON, Calif., Aug. 28, 2025 /PRNewswire/ -- Veeva Systems (NYSE:VEEV) today announced a collaboration with Amgen to advance clinical trial innovation. As a global leader in biotechnology, Amgen will employ the Veeva Clinical Platform to support and identify efficiencies across the clinical trial process, building on the company's commitment to accelerating the development of new medicines for patients with serious diseases. "In collaboration with Veeva, we're leveraging advanced technology to unlock new capabilities for our end-to-end trial operations which are expected
Total Revenues of $789.1M, up 17% Year Over YearSubscription Services Revenues of $659.2M, up 17% Year Over Year PLEASANTON, Calif., Aug. 27, 2025 /PRNewswire/ -- Veeva Systems Inc. (NYSE:VEEV), a leading provider of industry cloud solutions for the global life sciences industry, today announced results for its second quarter ended July 31, 2025. "It's exciting to see our vision of connected software, data, and business consulting for life sciences becoming a reality," said CEO Peter Gassner. "I am especially excited about the power of Veeva AI and Veeva Data Cloud to enable t
Alnylam Pharmaceuticals, BeOne Medicines, Intercept Pharmaceuticals, Merck, Pfizer, and Sanofi among biopharmas sharing strategies that set future direction Veeva to showcase innovations, including deep industry-specific Veeva AI in Vault Platform and Veeva applications PLEASANTON, Calif., Aug. 21, 2025 /PRNewswire/ -- Veeva Systems (NYSE:VEEV) today announced highlights of its upcoming Veeva R&D and Quality Summit, where leaders across life sciences and Veeva exchange impactful ideas and innovations. BeOne Medicines, Intercept Pharmaceuticals, Merck, and Pfizer are among the leaders coming together September 3-4 in Boston to share how they are advancing clinical, regulatory, safety, and qua
Global partnerships to help customers improve clinical and commercial efficiency and effectiveness IQVIA (NYSE:IQV) and Veeva Systems (NYSE:VEEV) today announced global clinical and commercial partnerships and the complete resolution of all pending legal disputes. Under the terms of the long-term agreement, customers can use software, data, technology, and service offerings from Veeva and IQVIA together in a simple and efficient way. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250818883712/en/ The global partnerships make it easy for customers to work with IQVIA and Veeva in key areas including: Commercial: The companies
10-Q - VEEVA SYSTEMS INC (0001393052) (Filer)
8-K - VEEVA SYSTEMS INC (0001393052) (Filer)
8-K - VEEVA SYSTEMS INC (0001393052) (Filer)
8-K - VEEVA SYSTEMS INC (0001393052) (Filer)
144 - VEEVA SYSTEMS INC (0001393052) (Subject)
DEFA14A - VEEVA SYSTEMS INC (0001393052) (Filer)
10-Q - VEEVA SYSTEMS INC (0001393052) (Filer)
8-K - VEEVA SYSTEMS INC (0001393052) (Filer)
DEFA14A - VEEVA SYSTEMS INC (0001393052) (Filer)
DEFA14A - VEEVA SYSTEMS INC (0001393052) (Filer)
Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.
4 - VEEVA SYSTEMS INC (0001393052) (Issuer)
4 - VEEVA SYSTEMS INC (0001393052) (Issuer)
4 - VEEVA SYSTEMS INC (0001393052) (Issuer)
4 - VEEVA SYSTEMS INC (0001393052) (Issuer)
4 - VEEVA SYSTEMS INC (0001393052) (Issuer)
4 - VEEVA SYSTEMS INC (0001393052) (Issuer)
4 - VEEVA SYSTEMS INC (0001393052) (Issuer)
4 - VEEVA SYSTEMS INC (0001393052) (Issuer)
4 - VEEVA SYSTEMS INC (0001393052) (Issuer)
4 - VEEVA SYSTEMS INC (0001393052) (Issuer)
Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.
Analyst upgraded Veeva Systems from Neutral to Overweight and set a new price target of $330.00
Needham reiterated coverage of Veeva Systems with a rating of Buy and set a new price target of $300.00 from $270.00 previously
Goldman downgraded Veeva Systems from Buy to Sell and set a new price target of $200.00 from $261.00 previously
Stephens initiated coverage of Veeva Systems with a rating of Overweight and set a new price target of $280.00
Mizuho initiated coverage of Veeva Systems with a rating of Outperform and set a new price target of $275.00
Scotiabank initiated coverage of Veeva Systems with a rating of Sector Perform and set a new price target of $235.00
Exane BNP Paribas initiated coverage of Veeva Systems with a rating of Outperform and set a new price target of $286.00
Citigroup reiterated coverage of Veeva Systems with a rating of Buy and set a new price target of $273.00 from $256.00 previously
BTIG Research initiated coverage of Veeva Systems with a rating of Buy and set a new price target of $240.00
Wells Fargo upgraded Veeva Systems from Equal Weight to Overweight and set a new price target of $229.00 from $211.00 previously
This live feed shows all institutional transactions in real time.
SC 13G/A - VEEVA SYSTEMS INC (0001393052) (Subject)
SC 13G/A - VEEVA SYSTEMS INC (0001393052) (Subject)
SC 13G/A - VEEVA SYSTEMS INC (0001393052) (Subject)
SC 13G/A - VEEVA SYSTEMS INC (0001393052) (Subject)
SC 13G/A - VEEVA SYSTEMS INC (0001393052) (Subject)
SC 13G/A - VEEVA SYSTEMS INC (0001393052) (Subject)
SC 13G/A - VEEVA SYSTEMS INC (0001393052) (Subject)
SC 13G/A - VEEVA SYSTEMS INC (0001393052) (Subject)
SC 13G/A - VEEVA SYSTEMS INC (0001393052) (Subject)
SC 13G/A - VEEVA SYSTEMS INC (0001393052) (Subject)
Live Leadership Updates
PLEASANTON, Calif., Jan. 25, 2022 /PRNewswire/ -- Veeva Systems (NYSE:VEEV) today announced the appointments of Tim Cabral, Priscilla Hung, Tina Hunt, and Marshall Mohr to its board of directors. Veeva also announced Ron Codd will retire from the board at the end of his current term in June 2022. "We are pleased to welcome Tim, Priscilla, Tina, and Marshall, who bring a range of experience in life sciences and enterprise software to the Veeva board," said Veeva CEO Peter Gassner. "I would also like to thank Ron Codd for a decade of partnership and contributions to Veeva." Th
BARCELONA, Spain--(BUSINESS WIRE)--Veeva Systems (NYSE: VEEV) announced that in an overwhelming majority vote, 99% of voting shareholders support the company’s proposal to become a public benefit corporation (PBC), including the vast majority of Veeva’s largest shareholders. With shareholder approval, Veeva will become a public benefit corporation on Feb. 1, 2021, making it the first publicly traded company and largest-ever to convert to a PBC. As a PBC, Veeva will remain a for-profit corporation but will be legally responsible to balance the interests of multiple stakeholders, including customers, employees, partners, and shareholders. It will also broaden its certificate of inc
PLEASANTON, Calif.--(BUSINESS WIRE)--Please replace the release with the following corrected version due to multiple revisions. The updated release reads: VEEVA BECOMES FIRST PUBLIC COMPANY TO CONVERT TO A PUBLIC BENEFIT CORPORATION Aligns legal charter with company’s long-term view and commitment to all stakeholders, including customers, employees, and shareholders Proposal passes by landslide as Veeva garners widespread support for leading in stakeholder capitalism Veeva Systems (NYSE: VEEV) announced that in an overwhelming majority vote today, 99% of voting shareholders support the company’s proposal to become a public benefit corporation (PBC), including the vast majorit
PLEASANTON, Calif.--(BUSINESS WIRE)--Veeva Systems (NYSE: VEEV) announced that in an overwhelming majority vote today, 99% of voting shareholders support the company’s proposal to become a public benefit corporation (PBC), including the vast majority of Veeva’s largest shareholders. With today’s shareholder approval, Veeva will become a public benefit corporation on Feb. 1, 2021, making it the first publicly traded company and largest-ever to convert to a PBC. As a PBC, Veeva will remain a for-profit corporation but will be legally responsible to balance the interests of multiple stakeholders, including customers, employees, partners, and shareholders. It will also broaden its ce
Live finance-specific insights
Total Revenues of $789.1M, up 17% Year Over YearSubscription Services Revenues of $659.2M, up 17% Year Over Year PLEASANTON, Calif., Aug. 27, 2025 /PRNewswire/ -- Veeva Systems Inc. (NYSE:VEEV), a leading provider of industry cloud solutions for the global life sciences industry, today announced results for its second quarter ended July 31, 2025. "It's exciting to see our vision of connected software, data, and business consulting for life sciences becoming a reality," said CEO Peter Gassner. "I am especially excited about the power of Veeva AI and Veeva Data Cloud to enable t
PLEASANTON, Calif., Aug. 6, 2025 /PRNewswire/ -- Veeva Systems (NYSE:VEEV) will announce financial results for its second quarter, which ended July 31, 2025, after market close on August 27, 2025. Veeva will host a conference call and webcast that day at 2:00 p.m. PT (5:00 p.m. ET) to discuss its financial results. Veeva will post prepared remarks to its investor relations website at https://ir.veeva.com at approximately 1:05 p.m. PT (4:05 p.m. ET). A webcast replay will be available on the website following the live event. Event: Veeva Systems' Fiscal 2026 Second Quarter Results Conference Call Date: Wednesday, August 27, 2025 Time: 2:00 p.m. PT (5:00 p.m. ET) Conference Call Registrati
Total Revenues of $759.0M, up 17% Year Over YearSubscription Services Revenues of $634.8M, up 19% Year Over Year PLEASANTON, Calif., May 28, 2025 /PRNewswire/ -- Veeva Systems Inc. (NYSE:VEEV), a leading provider of industry cloud solutions for the global life sciences industry, today announced results for its first quarter ended April 30, 2025. "I consider this our best first quarter ever. We executed with speed, quality, and innovation across all areas on short-term objectives and long-term initiatives aligned to our values and 2030 goals," said CEO Peter Gassner. "Thanks t
PLEASANTON, Calif., May 7, 2025 /PRNewswire/ -- Veeva Systems (NYSE:VEEV) will announce financial results for its first quarter, which ended April 30, 2025, after market close on May 28, 2025. Veeva will host a conference call and webcast that day at 2:00 p.m. PT (5:00 p.m. ET) to discuss its financial results. Veeva will post prepared remarks to its investor relations website at https://ir.veeva.com at approximately 1:05 p.m. PT (4:05 p.m. ET). A webcast replay will be available on the website following the live event. Event: Veeva Systems' Fiscal 2026 First Quarter Results Conference Call Date: Wednesday, May 28, 2025 Time: 2:00 p.m. PT (5:00 p.m. ET) Conference Call Registration: https:/
Fiscal Year 2025 Total Revenues of $2,746.6M, up 16% Year Over YearQ4 Total Revenues of $720.9M, up 14% Year Over Year Fiscal Year 2025 Subscription Services Revenues of $2,284.7M, up 20% Year Over YearQ4 Subscription Services Revenues of $608.6M, up 17% Year Over Year PLEASANTON, Calif., March 5, 2025 /PRNewswire/ -- Veeva Systems Inc. (NYSE:VEEV), a leading provider of industry cloud solutions for the global life sciences industry, today announced results for its fourth quarter and fiscal year ended January 31, 2025. "It was an outstanding quarter and year of execution and i
PLEASANTON, Calif., Feb. 12, 2025 /PRNewswire/ -- Veeva Systems (NYSE:VEEV) will announce financial results for its fourth quarter and full fiscal year, which ended January 31, 2025, after market close on March 5, 2025. Veeva will host a conference call and webcast that day at 2:00 p.m. PT (5:00 p.m. ET) to discuss its financial results. Veeva will post prepared remarks to its investor relations website at https://ir.veeva.com at approximately 1:05 p.m. PT (4:05 p.m. ET). A webcast replay will be available on the website following the live event. Event: Veeva Systems' Fiscal 2025 Fourth Quarter and Full Year Results Conference Call Date: Wednesday, March 5, 2025 Time: 2:00 p.m. PT (5:00 p.m
Total Revenues of $699.2M, up 13% Year Over YearSubscription Services Revenues of $580.9M, up 17% Year Over Year PLEASANTON, Calif., Dec. 5, 2024 /PRNewswire/ -- Veeva Systems Inc. (NYSE:VEEV), a leading provider of industry cloud solutions for the global life sciences industry, today announced results for its third quarter ended October 31, 2024. "It was a great quarter of innovation and excellent execution across the board," said CEO Peter Gassner. "Especially significant was the hard work for the long term. We deepened a number of large, highly strategic relationships and a
PLEASANTON, Calif., Nov. 14, 2024 /PRNewswire/ -- Veeva Systems (NYSE:VEEV) will announce financial results for its third quarter, which ended October 31, 2024, after market close on December 5, 2024. Veeva will host a conference call and webcast that day at 2:00 p.m. PT (5:00 p.m. ET) to discuss its financial results. Veeva will post prepared remarks to its investor relations website at https://ir.veeva.com at approximately 1:05 p.m. PT (4:05 p.m. ET). A webcast replay will be available on the website following the live event. Event: Veeva Systems' Fiscal 2025 Third Quarter Results Conference Call Date: Thursday, December 5, 2024 Time: 2:00 p.m. PT (5:00 p.m. ET) Conference Call Registr
Total Revenues of $676.2M, up 15% Year Over Year;Subscription Services Revenues of $561.3M, up 19% Year Over Year PLEASANTON, Calif., Aug. 28, 2024 /PRNewswire/ -- Veeva Systems Inc. (NYSE:VEEV), a leading provider of industry cloud solutions for the global life sciences industry, today announced results for its second quarter ended July 31, 2024. "It was another quarter of great execution, with major product advances in clinical and CRM that position us well for the industry cloud opportunity we see ahead," said CEO Peter Gassner. "Thanks to the team's focus on product excell
PLEASANTON, Calif., Aug. 7, 2024 /PRNewswire/ -- Veeva Systems (NYSE:VEEV) will announce financial results for its second quarter, which ended July 31, 2024, after market close on August 28, 2024. Veeva will host a conference call and webcast that day at 2:00 p.m. PT (5:00 p.m. ET) to discuss its financial results. Veeva will post prepared remarks to its investor relations website at https://ir.veeva.com approximately at 1:05 p.m. PT (4:05 p.m. ET). A webcast replay will be available on the website following the live event. Event: Veeva's Fiscal 2025 Second Quarter Results Conference Call Date: Wednesday, August 28, 2024 Time: 2:00 p.m. PT (5:00 p.m. ET) Conference Call Registration: htt